Research suggests FOXO4-DRI targets senescent cells by disrupting the FOXO4p53 interaction, allowing damaged cells to undergo apoptosis
Inoue N, Ogura S, Kasai A, Nakazawa T, Ikeda K, Higashi S, Isotani A, Baba K, Mochizuki H, Fujimura H, Ago Y, Hayata-Takano A, Seiriki K, Shintani Y, Shintani N, Hashimoto H (2018) Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism
For those truly low on B12, getting injectable B12 for humans can be transformative
Alterations in circulating estradiol-17-beta in male patients with Graves's disease
The KLOW blend contains four synthetic peptides: BPC-157 at 50mg, TB-500 at 10mg, KPV (Lys-Pro-Val) at 10mg, and GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) at 10mg 80mg total in 3mL
However, it is important to have realistic expectations and understand the facts surrounding its use